Successful Human Trial Completed!
August 23, 2024
August 23, 2024
The Sentante Endovascular Robotic System has hit a major milestone, completing its first in human clinical study led by Dainis Krievins, MD, PhD in Riga, Latvia. Over three weeks, 10 patients underwent 21 fully robotic procedures!
Sentante‘s fully robotic, remote-operated system shields medical teams from radiation while ensuring precision with haptic feedback. This breakthrough promises to transform endovascular treatment, enhancing safety for patients and healthcare providers.
Get ready for Sentante‘s global launch next year!
Our latest
news and publications
news and publications
-
Read
Sentante accepted into FDA Total Product Life Cycle Advisory Program following Breakthrough Device DesignationFebruary 13, 2026 -
Read
Sentante Accelerates Remote Stroke Surgery Innovation With First Live TrialsDecember 12, 2025 -
Read
Critical Stroke Procedure Performed from Across the AtlanticNovember 11, 2025